|
Volumn 67, Issue 6, 2006, Pages 1470-1471
|
Differentiation therapy as an effective strategy for the treatment of chronic myelogenous leukemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
CYTARABINE;
GUANOSINE TRIPHOSPHATE;
IMATINIB;
NUCLEOTIDE;
PHOSPHOTRANSFERASE INHIBITOR;
RETINOIC ACID;
ABSENCE OF SIDE EFFECTS;
APOPTOSIS;
BONE MARROW TRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CELL DIFFERENTIATION;
CELL FUNCTION;
CELL PROLIFERATION;
CELL SURVIVAL;
CHROMOSOME 22;
CHROMOSOME 9;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
HEMATOPOIETIC STEM CELL;
HUMAN;
LETTER;
ONCOGENE;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
CELL AGING;
CELL DIFFERENTIATION;
GUANOSINE TRIPHOSPHATE;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
LEUKEMIA, MYELOID, CHRONIC;
MODELS, BIOLOGICAL;
NEOPLASTIC STEM CELLS;
PIPERAZINES;
PYRIMIDINES;
TUMOR STEM CELLS;
|
EID: 33748967007
PISSN: 03069877
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mehy.2006.06.022 Document Type: Letter |
Times cited : (4)
|
References (5)
|